Histogen's FINAL Phase I/IIa Results (2013)

[The Alchemist]

Clinical chemistry showed no indication of
toxicity or blood/urine abnormalities in the
general patient population following both sets
of HSC injection. Clinical evaluation of blood
serum chemistry, hematology and urinalysis
showed no changes from baseline over the course
of the treatment. Figures above show the serum
blood chemistry and hematology values obtained
at baseline (pre-treatment), 4 weeks and 12
weeks. No evidence of toxicity is observed in any
of the clinical indicators


So, how is it that Histogen can come to these conclusions and in the very same poster demonstrate that Follistatin is inhibiting hemoglobin levels?

Anyone know what Max% OD stands for?